Xingchao Zhu
178 East Ganjiang Road
Suzhou, 215000, China
Suzhou, 215000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A multi-omic analysis delineates a causal protective role for Bifidobacteriaceae and implicates key host genes in inflammatory bowel disease.
Journal: PeerJ
Published: September 09, 2025
Dysregulated Cholesterol Metabolism and Its Impact on the Tumour Immune Response in Colorectal Cancer.
Journal: Journal of cellular and molecular medicine
Published: March 31, 2025
Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 09, 2024
Intermittent Fasting and Fasting-mimicking Diet: Promising Strategies in Cancer Management.
Journal: Current medicinal chemistry
Published: July 03, 2024
B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway.
Journal: Tissue & cell
Published: May 13, 2024
Downregulated KLF4, induced by m6A modification, aggravates intestinal barrier dysfunction in inflammatory bowel disease.
Journal: Cellular and molecular life sciences : CMLS
Published: April 16, 2024
Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 15, 2015
Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin.
Journal: Medical oncology (Northwood, London, England)
Published: March 04, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026